189 related articles for article (PubMed ID: 37756582)
21. Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial.
Johnson CC; Hayes RB; Schoen RE; Gunter MJ; Huang WY;
Am J Gastroenterol; 2010 Dec; 105(12):2646-55. PubMed ID: 20808298
[TBL] [Abstract][Full Text] [Related]
22. Can We Select Patients for Colorectal Cancer Prevention with Aspirin?
Kraus S; Sion D; Arber N
Curr Pharm Des; 2015; 21(35):5127-34. PubMed ID: 26369678
[TBL] [Abstract][Full Text] [Related]
23. [Aspirin for Chemoprevention of Colorectal Adenoma and Cancer].
Ishikawa H
Gan To Kagaku Ryoho; 2021 Dec; 48(12):1425-1428. PubMed ID: 34911904
[TBL] [Abstract][Full Text] [Related]
24. A study of prostaglandin pathway genes and interactions with current nonsteroidal anti-inflammatory drug use in colorectal adenoma.
Edwards TL; Shrubsole MJ; Cai Q; Li G; Dai Q; Rex DK; Ulbright TM; Fu Z; Murff HJ; Smalley W; Ness R; Zheng W
Cancer Prev Res (Phila); 2012 Jun; 5(6):855-63. PubMed ID: 22551900
[TBL] [Abstract][Full Text] [Related]
25. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
[TBL] [Abstract][Full Text] [Related]
26. The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland.
Macarthur M; Sharp L; Hold GL; Little J; El-Omar EM
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1613-8. PubMed ID: 16030091
[TBL] [Abstract][Full Text] [Related]
27. Changes in PTGS1 and ALOX12 Gene Expression in Peripheral Blood Mononuclear Cells Are Associated with Changes in Arachidonic Acid, Oxylipins, and Oxylipin/Fatty Acid Ratios in Response to Omega-3 Fatty Acid Supplementation.
Berthelot CC; Kamita SG; Sacchi R; Yang J; Nording ML; Georgi K; Hegedus Karbowski C; German JB; Weiss RH; Hogg RJ; Hammock BD; Zivkovic AM
PLoS One; 2015; 10(12):e0144996. PubMed ID: 26672987
[TBL] [Abstract][Full Text] [Related]
28. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
[TBL] [Abstract][Full Text] [Related]
29. Inflammation-related gene polymorphisms and colorectal adenoma.
Gunter MJ; Canzian F; Landi S; Chanock SJ; Sinha R; Rothman N
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1126-31. PubMed ID: 16775170
[TBL] [Abstract][Full Text] [Related]
30. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
[TBL] [Abstract][Full Text] [Related]
31. Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review.
Asano TK; McLeod RS
Dis Colon Rectum; 2004 May; 47(5):665-73. PubMed ID: 15054679
[TBL] [Abstract][Full Text] [Related]
32. Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations.
Sheth H; Northwood E; Ulrich CM; Scherer D; Elliott F; Barrett JH; Forman D; Wolf CR; Smith G; Jackson MS; Santibanez-Koref M; Haile R; Casey G; Jenkins M; Win AK; Hopper JL; Marchand LL; Lindor NM; Thibodeau SN; Potter JD; Burn J; Bishop DT
PLoS One; 2018; 13(2):e0192223. PubMed ID: 29425227
[TBL] [Abstract][Full Text] [Related]
33. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
34. Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial.
Ishikawa H; Wakabayashi K; Suzuki S; Mutoh M; Hirata K; Nakamura T; Takeyama I; Kawano A; Gondo N; Abe T; Tokudome S; Goto C; Matsuura N; Sakai T
Cancer Med; 2013 Feb; 2(1):50-6. PubMed ID: 24133627
[TBL] [Abstract][Full Text] [Related]
35. Aspirin for the prevention of colorectal cancer.
Garcia-Albeniz X; Chan AT
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):461-72. PubMed ID: 22122763
[TBL] [Abstract][Full Text] [Related]
36. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.
Grau MV; Baron JA; Barry EL; Sandler RS; Haile RW; Mandel JS; Cole BF
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2353-8. PubMed ID: 16214916
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
[TBL] [Abstract][Full Text] [Related]
38. Aspirin and the prevention of colorectal cancer: a review of the evidence.
Paganini-Hill A
Semin Surg Oncol; 1994; 10(3):158-64. PubMed ID: 8085092
[TBL] [Abstract][Full Text] [Related]
39. Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma.
Chan AT; Tranah GJ; Giovannucci EL; Hunter DJ; Fuchs CS
J Natl Cancer Inst; 2005 Mar; 97(6):457-60. PubMed ID: 15770010
[TBL] [Abstract][Full Text] [Related]
40. Aspirin and NSAIDs for the prevention of colorectal cancer.
Baron JA
Recent Results Cancer Res; 2009; 181():223-9. PubMed ID: 19213572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
